Table 2. Relationships between model variables and clinical variables in the entire TCGA cohort.
| Variables | Age (>60/≤60) | Gender (male/female) | Histological grade (I&II/III&IV) | Pathological stage (I&II/III&IV) |
| t (p) | t (p) | t (p) | t (p) | |
| PLAU | -0.066 (0.948) | 0.119 (0.905) | -3.543 (4.38E-04) | -2.925 (0.004) |
| ISG15 | -1.271 (0.204) | -0.556 (0.578) | -1.775 (0.077) | -3.102 (0.002) |
| IRF9 | 0.345 (0.730) | 1.657 (0.098) | -1.437 (0.151) | -3.06 (0.002) |
| ARG2 | -0.546 (0.585) | 0.932 (0.352) | -1.907 (0.057) | -1.176 (0.241) |
| RNASE2 | -0.726 (0.468) | -1.482 (0.139) | -4.567 (6.661E-06) | -3.65 (3.188E-04) |
| SEMA3G | 1.514 (0.131) | 1.838 (0.067) | 6.734 (4.912E-11) | 7.447 (4.098E-13) |
| UCN | -1.973 (0.049) | 0.312 (0.755) | -3.631 (3.136E-04) | -3.995 (8.179E-05) |
| Risk score | -1.636 (0.102) | -0.271 (0.786) | -5.946 (6.849E-09) | -5.521 (8.964E-08) |
t: t value from Student’s t test; p: p-value from Student’s t test.